Genetics of Familial Testicular Cancer
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Studies of Familial Testicular Germ Cell Tumors
Sponsor: National Cancer Institute (NCI)
This observational or N/A phase trial investigates Testicular Cancer and is currently completed. National Cancer Institute (NCI) leads this study, which shows 24 recorded versions since 2004 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
24 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 19 earlier versions
-
Aug 2020 — Nov 2020 [monthly]
Completed
-
Mar 2020 — Aug 2020 [monthly]
Completed
-
Feb 2020 — Mar 2020 [monthly]
Completed
-
Jan 2020 — Feb 2020 [monthly]
Completed
-
Dec 2019 — Jan 2020 [monthly]
Completed
-
Oct 2019 — Dec 2019 [monthly]
Completed
-
Aug 2019 — Oct 2019 [monthly]
Completed
-
May 2019 — Aug 2019 [monthly]
Completed
-
Apr 2019 — May 2019 [monthly]
Completed
-
Mar 2019 — Apr 2019 [monthly]
Completed
-
Feb 2019 — Mar 2019 [monthly]
Completed
-
Nov 2018 — Feb 2019 [monthly]
Completed
-
Oct 2018 — Nov 2018 [monthly]
Completed
-
Sep 2018 — Oct 2018 [monthly]
Completed
-
Jun 2018 — Sep 2018 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Sep 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Sep 2017 [monthly]
Completed NA
First recorded
Jan 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .